Microsoft has ended support for its pre-IE11 browsers as of January 2016 and will be discontinuing IE11 support in August 2021.

If you are seeing this message, you are viewing the site on one of these unsupported browsers. We only support the recent versions of major browsers such as Chrome, Firefox, Safari, and Edge.

Thank you.

(click to close and continue using this browser)

Latest News

News from the IBIS Board of Directors, April 2018

IBIS friends and colleagues,

A Hemochromatosis International Taskforce composed of experts in the field of hemochromatosis (headed by P. Santos and P. Brisssot) has composed and made public a consensus statement about “Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.” The statement appeared recently, with open access, in Hepatology International.

Read More

The Board of Directors of IBIS, the International BioIron Society, endorse those recommendations, salutes the participants in the above task force and acknowledges the collaboration with Hemochomatosis International and other local and international societies open to cooperating with IBIS in the Study of Iron in Biology and Medicine.

Ioav Cabantchik (Professor Emeritus)
IBIS President

posted: April 2, 2018